ADMA(ADMA Biologics, Inc.) · 财务报表

ADMA(ADMA Biologics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$80.94M$154.08M$258.21M$426.45M$510.17M
毛利润$1.17M$35.27M$88.94M$219.55M$292.76M
营业利润−$58.37M−$39.37M$21.63M$138.98M$191.44M
净利润−$71.65M−$65.90M−$28.24M$197.67M$146.93M
经营现金流−$112.37M−$59.51M$8.80M$118.67M$50.40M
自由现金流−$125.88M−$73.42M$4.03M$110.45M$27.82M
摊薄每股收益$-0.51$-0.33$-0.13$0.81$0.60

ADMA Biologics, Inc. ADMA